The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی
|
|
|
- Julian Dickerson
- 5 years ago
- Views:
Transcription
1 The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 1
2 Expanded to include Gambling Disorder Cannabis Withdrawal and Caffeine Withdrawal are new disorders Caffeine Withdrawal was in DSM-IV Appendix B for further study DSM-5 does not separate abuse and dependence but criteria is provided for Substance Use Disorder 2
3 The substance-related disorders are divided into two groups: Substance Use Disorders Substance-induced Disorders: Intoxication Withdrawal Other substance/medication-induced mental disorders 3
4 Recurrent substance-related legal problems criteria deleted Threshold for diagnosis is set at two or more criteria while in DSM-IV it was one or more for abuse and three or more for dependence Diagnosis of polysubstance dependence in DSM- IV is eliminated Criteria for intoxication, withdrawal, substanceinduced disorders and unspecified substancerelated disorders 4
5 Early remission for a DSM-5 substance use disorder is defined as at least 3months but less than 12 months without meeting criteria (except craving) Sustained remission is defined as over 12 months Additional DSM-5 specifiers include In a controlled environment On maintenance therapy 5
6 The essential feature of a substance use disorder is a cluster of cognitive, behavioral and physiological symptoms indicating the individual continues using the substance despite significant substance-related problems. The diagnosis of substance use disorder can be applied to all 10 classes with the exception of caffeine 6
7 10 Classes of Substances in DSM-5 ALCOHOL CAFFEINE CANNABIS HALLUCINOGENS ( includes phencyclidine) INHALANTS OPIOIDS SEDATIVES,HYPNOTICS OR ANXIOLYTICS STIMULANTS TOBACCO OTHER OR UNKNOWN 7
8 The behavioral effects of these brain changes may be exhibited in the repeated relapses and intense drug craving when the individuals are exposed to drug-related stimuli. These persistent drug effects may benefit from longterm approaches to treatment. The diagnosis is based upon a pathological pattern of behaviors 8
9 Pathological pattern of behaviors CRITERION A Criteria 1-4- Impaired control over substance use Criterion 4- Craving Criteria 5-7-Social impairment Criteria 8-9- Risky use of the substance Criterion 9- Failure to abstain despite the difficulties caused by the usage Criteria Pharmacological criteria Criterion 10- Tolerance Criterion 11- Withdrawal 9
10 CRITERION A Impaired control 1. Taking the substance in larger amount or over a longer period than originally intended 2. Persistent desire to cut down or regulate use and failure in attempting to do so 3. Spends a great deal of time procuring, using and recovering from the effects of intake 4. Craving-an intense desire to use especially when around triggers of use 10
11 CRITERION A Social impairment 5. Failure to fulfill major role obligations at work, school or home 6. Continued use despite these adverse consequences 7. Important social, occupational or recreational activities given up or reduced due to substance use 11
12 CRITERION A Risky use 8. Use in situations that could be physically hazardous 9. Failure to abstain despite knowledge of a physical or psychological problem likely caused or exacerbated by use (the problem is the failure not abstain and not the problem) 12
13 CRITERION A Pharmacological 10. Tolerance 11. Withdrawal or acute abstinence syndrome 13
14 Neither tolerance nor withdrawal is necessary to diagnose a substance-use disorder Symptoms of tolerance and withdrawal from prescribed medications taken as directed is not substance use disorder Broad range of severity based upon number of symptom criteria 14
15 General estimate of severity MILD- 2 or 3 symptoms MODERATE- 4 or 5 symptoms SEVERE- 6 or more symptoms Recording Procedure (F15.10)- Moderate Alprazolam Use Disorder (not sedative, hypnotic or anxiolytic disorder) 15
16 EXAMPLE: OPIOID-RELATED Opioid Use Disorder Opioid Intoxication Opioid Withdrawal Other Opioid-Induced Disorders Unspecified Opioid-Related Disorders 16
17 Opioid Use Disorder Based upon the 11 criteria and specifiers (F11.10)-MILD Opioid Use Disorder (F11.20)-MODERATE Opioid Use Disorder (F11.20)-SEVERE Opioid Use Disorder Opioid Intoxication (F11.129) Based upon criteria for recent use, clinically significant behavioral or psychological changes, pupillary constriction and other signs of opioid use not attributable to other medical conditions 17
18 Opioid Withdrawal (F11.23) Based upon cessation or reduction in dose or administration of an antagonist plus three or more of symptoms associated with opioid withdrawal producing distress or impairment Other Opioid-Induced Disorders Opioid-induced depressive disorder (see under Depressive Disorders) Unspecified Opioid-Related Disorder (F11.99) Where symptoms of an Opioid-Related Disorder exist causing significant distress but not meeting full criteria 18
Substance Use Disorders
Substance Use Disorders Substance Use Disorder This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
PRACTICE ALERT. New ICD Code Changes. Mirean Coleman, LICSW, CT Clinical Manager. December 2017
PRACTICE ALERT New ICD Code Changes Mirean Coleman, LICSW, CT Clinical Manager December 2017 Each year the National Center for Health Statistics (NCHS), releases new, updated, or deleted codes for the
_._ L.---l Alcohol Use Disorder'': b (490) Speciftj current severity: (FiO.10) Mild (F10.20) (1=10.20)
DSM-5 Classification xxv Substance-Related - - -- and Addictive.".: Disorders -- (481) The following specifiers and note apply to Substance-Related and Addictive Disorders where indicated: aspecify if:
Clinical Evaluation: Assessment Goals
Clinical Evaluation: Assessment Goals 1. Define Assessment Process 2. Identify Assessment Instruments 3. Define DSM-5 criteria for Substance Abuse and Dependence, specifiers and multi-axial assessment
Feeding and Eating Disorders
The Time is Here: Differential Diagnosis and Coding Using the DSM 5 and ICD 10 Diane Snow, PhD, RN, PMHNP-BC, FAANP, FIAAN University of Texas at Arlington College of Nursing and Health Innovation IntNSA
Opioid Use Issues: All the Players
Opioid Use Issues: All the Players Objectives After review, the participant will be able to: 1) Identify criteria for opioid use disorders Andrew J. McLean, MD, MPH Medical Director, ND Department of Human
DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW
DSM-5 AND ASAM CRITERIA Presented by Jaime Goffin, LCSW MODULE 1: GOALS & OBJECTIVES What is your experience with using ASAM and DSM 5 criteria? What are your learning expectations for today? GOAL FOR
Neurobiology of Drug Abuse and Addiction PSYC 450
Neurobiology of Drug Abuse and Addiction PSYC 450 Healthy Control Drug Abuser Illicit drug use, lifetime and past year, in Canada 50 Canabis only Any drug Any of 5 drugs (without canabis) (CADUMS 2012)
Clinical and public health significance of the proposed changes to the diagnosis of alcohol abuse and dependence in DSM-5
Clinical and public health significance of the proposed changes to the diagnosis of alcohol abuse and dependence in DSM-5 Dr Tim Slade, Senior Research Fellow, National Drug and Alcohol Research Centre,
Polysubstance Use & Medication-Assisted Treatment
Polysubstance Use & Medication-Assisted Treatment DSM-V eliminated polysubstance disorder, instead specifying each drug of abuse and dependence. Substance-use disorder is a combination of the two DSM-IV
DSM-5 UPDATE. Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION
DSM-5 UPDATE Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION October 2017 DSM-5 Update October 2017 Supplement to Diagnostic and Statistical Manual of Mental Disorders,
SCID-I Version 2.0 (for DSM-IV) Non-Alcohol Use Disorders
SCID-I Version 2.0 (for DSM-IV) Non-Alcohol Use Disorders *NON-ALCOHOL SUBSTANCE USE DISORDERS* (LIFETIME DEPENDENCE AND ABUSE) Now I am going to ask you about your use of drugs or medicines. SHOW DRUG
INDIANA HEALTH COVERAGE PROGRAMS
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Division of Mental Health and Addiction (DMHA) Behavioral and Primary Healthcare Coordination (BPHC) Codes Note: Due to possible changes in Indiana
THE ADDICTIVE BRAIN SC 212 JANUARY 3, 2017 JOHN BUSH
THE ADDICTIVE BRAIN SC 212 JANUARY 3, 2017 JOHN BUSH ADDICTS ADDICTIONS? WHAT CAUSES ADDICTIONS? Addiction is the result of substance abuse by people with moral failings or personality defects. Addiction
FAA Policy and Regulations. Agenda
FAA Policy and Regulations Presented to: 4 th Annual Aerospace Psychology Seminar By: Penny Giovanetti, D.O., MSPH Date: September 17, 2016 Agenda Safety of the National Air Space Medical Certification
Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V
Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V Helen Keane School of Sociology Australian National University Addiction A hybrid moral medical category defined by pathological
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
substance use and mental disorders: one, the other, or both?
substance use and mental disorders: one, the other, or both? Stephen Strobbe, PhD, RN, PMHCNS-BC, CARN-AP Dawn Farm Education Series St. Joe s Education Center, Ypsilanti, MI Tuesday, January 27, 2015
Addiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine
Addiction Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine Twitter: @rcwallermd Objectives Understand the Concept of Addiction Survival FOOD WATER DOPAMINE
FAA Medical Certification
FAA Medical Certification 5 th Annual Aerospace Psychology Seminar Sept 23, 2017 Denver, CO Presented to: AME Seminar By: Courtney Scott, DO, MPH Date: 1 November 2012 Aerospace Medical Certification Division
INDIANA HEALTH COVERAGE PROGRAMS
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Medicaid Rehabilitation Option (MRO) Services Codes Note: Due to possible changes in Indiana Health Coverage Programs (IHCP) policy or national coding
SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES
12/26/ Fear of the unknown prevents one from embracing the future.
Fear of the unknown prevents one from embracing the future. 12/26/2017 1 12/26/2017 2 The American Psychiatric Association first published a predecessor to the DSM in 1844. It was a statistical classification
Commi ee Lecture: Neurocogni ve Disorders TBI : Trauma c Brain Disorders. William L. Bograkos, MA, DO, FACOEP
Commi ee Lecture: Neurocogni ve Disorders TBI : Trauma c Brain Disorders Toxic Brain Disorders William L. Bograkos, MA, DO, FACOEP TBI: Traumatic Brain Injury / Toxic Brain Injury (Trauma and Substance
Survey of Temporary Assistance For Needy Families (TANF) Recipients
State of Oklahoma State Treatment Needs Assessment Program Phase II CSAT Contract No. 270-98-7066 September 30, 2001 Survey of Temporary Assistance For Needy Families (TANF) Recipients EXECUTIVE SUMMARY
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
Mental Disorders with Associated Harmful Behavior and Substance-Related Disorders
Mental Disorders with Associated Harmful Behavior and Substance-Related Disorders Kishore Desagani, MD General Adult and Forensic Psychiatrist Consultant Psychiatrist Medical Assessment and Policy Team
Important Information
Important Information Please work through the following pages with your patient or the patient s chart as necessary. Fax completed documents to 1 888 629-4722. Keep the original in your chart / file. Fee:
BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH
BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH THERAPEUTIC INTERVENTION AND RESOURCE MANAGEMENT: SUBSTANCE RELATED DISORDERS: CO-DEPENDENCY AND THE IMPAIRED NURSE LECTURE OBJECTIVES:
DSM-5 Table of Contents
DSM-5 Table of Contents DSM-5 Classification Preface Section I: DSM-5 Basics Introduction Use of DSM-5 Cautionary Statement for Forensic Use of DSM-5 Section II: Essential Elements: Diagnostic Criteria
Appendix F Federation of State Medical Boards
Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction
A look at Marijuana in 2014
A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5
PerformCare Provider Network Scott Daubert PhD, VP Provider Network & Account Management. AD ICD-10-CM Frequently Asked Questions
Provider Notice To: From: PerformCare Provider Network Scott Daubert PhD, VP Provider Network & Account Management Date: April 23, 2015 Subject: AD 15 105 ICD-10-CM Frequently Asked Questions The Centers
Classification of Abuse-Related Events in Analgesic Clinical Trials: Recommendations and Research Agenda
Classification of Abuse-Related Events in Analgesic Clinical Trials: Recommendations and Research Agenda Nathaniel Katz, MD, MS Analgesic Research, Needham, MA Tufts University, Boston, MA IMMPACT XII,
Chapter 7. Screening and Assessment
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
Substance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %
Substance Use Disorders A Major Problem Lifetime rates of alcoholism estimated at 13.4 % Rates of drug abuse estimated at 6% Marijuana is most frequent Approximately 600,000 deaths each year from substance
Opiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic
Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic Lucas Buffaloe, MD Associate Professor of Clinical Family and Community Medicine University of Missouri Health Care Goals for today
ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH
ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV
Substance Use and Addictive Disorders
Key Dates TU Feb 14 Unit 8 147-end and Unit 9; MW Ch 8 Jeffrey and Ch 10 Diana TH Feb 16 Unit 10; MW Ch 11 Theodore B TU Feb 21 Monday class schedule TH Feb 23 Begin Dimensions-Cognition, Units IIC and
NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and
Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC
Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01
Common Diagnosis Codes and Tips for Coding Nicotine Use/
ICD-10 Tobacco Billing Guide ICD-10 and Tobacco Common Diagnosis Codes and Tips for Coding Nicotine Use/ Dependence Tobacco use is the leading cause of preventable disease and death in the United States,
NEW AND REVISED DSM DISORDERS. Disruptive Mood Dysregulation Disorder Autism Spectrum Disorders Substance Use Disorders
NEW AND REVISED DSM DISORDERS Disruptive Mood Dysregulation Disorder Autism Spectrum Disorders Substance Use Disorders Objectives 1. Identify the rationale for the Disruptive Mood Dysregulation Disorder
A HELPFUL WALK THROUGH DSM-5
A HELPFUL WALK THROUGH DSM-5 ROGER SHAFER, MD UNITY POINT-FINLEY SUMMIT CENTER FOR OLDER ADULTS DUBUQUE, IA OBJECTIVES The learner will identify the foundational differences between the DSM-5 and the previous
Profile of PAES Recipients and Factors That Influence PAES Outcomes
` San Francisco Department of Human Services County Adult Assistance Programs Personal Assisted Employment Services Program Profile of PAES Recipients and Factors That Influence PAES Outcomes Analysis
KAP Keys. For Clinicians. Based on TIP 24 A Guide to Substance Abuse Services for Primary Care Clinicians. CSAT s Knowledge Application Program
KAP KEYS Based on TIP 24 A Guide to Substance Abuse Services for Primary Care CSAT s Knowledge Application Program KAP Keys For Based on TIP 24 A Guide to Substance Abuse Services for Primary Care U.S.
MASS COMMUNICATIONS The traditional realm of mass communications includes television,
Appendix C: Perspectives on Defining Substance c Abuse F our broad arenas that encounter substance abuse-related issues include, mass communications, criminal justice, medicine, and public health. These
Module Three Screening and Assessment V
Module Three Screening and Assessment V1.7.13.141031 Introduction to Modules Three and Four Modules Three and Four cover the key components of SBIRT screening, assessment and brief intervention. The screening,
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING
Overview. APPLIED PREVENTION & intervention STRATEGIES. APPLIED PREVENTION & intervention STRATEGIES
Overview in the Context of a Comprehensive System of Care Overview of Evidence-Based Brief Motivational Interventions Screening and Referral Overview Session 1 Session 2 2 APPLIED PREVENTION & intervention
Substance Use/Abuse Coding Fact Sheet for Primary Care Pediatrics
1/1/13 CPT (Procedure) Codes Substance Use/Abuse Coding Fact Sheet for Primary Care Pediatrics Initial assessment usually involves a lot of time determining the differential diagnosis, a diagnostic plan,
Alcohol Misuse Clinical Pathway Outline
Alcohol Misuse Clinical Pathway Outline 1. Identification of Patients for Alcohol Misuse Pathway a. Criteria for inclusion into alcohol misuse clinical pathway: Patients meeting the following criteria
*Many of these DSM 5 Diagnoses might also be used to argue for eligibility using Other Health Impaired Criteria
Handout 2: DSM 5 Diagnoses that May be Associated with One or More of the Five ED Characteristics* 1. An inability to learn that cannot be explained by intellectual, sensory, or health factors. a) Selective
March 29, 2017 Debra K. Smith, Ph.D. St. Charles Hospital Port Jefferson, New York
Traumatic Brain Injury: Management of Psychological and Behavioral Sequelae March 29, 2017 Debra K. Smith, Ph.D. St. Charles Hospital Port Jefferson, New York The Functional Impact of
Mental Health Nursing: Substance-Related Disorders. By Mary B. Knutson, RN, MS, FCP
Mental Health Nursing: Substance-Related Disorders By Mary B. Knutson, RN, MS, FCP History of Psychoactive Substances Used by people in almost all cultures since prehistoric times Produce effects in the
7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER ELEVEN CHAPTER OUTLINE. Substance Use Disorders. Oltmanns and Emery
ABNORMAL PSYCHOLOGY SEVENTH EDITION Oltmanns and Emery PowerPoint Presentations Prepared by: Ashlea R. Smith, Ph.D. This multimedia and its contents are protected under copyright law. The following are
The Role of the PDMP: Foundational Knowledge and Best Practices
The Role of the PDMP: Foundational Knowledge and Best Practices Brent I. Fox, PharmD, PhD Health Outcomes Research and Policy Harrison School of Pharmacy Auburn University DISCLOSURE I, Brent Fox, have
A Comprehensive Model of Stepped Care for Substance Misuse Prevention on a College Campus
A Comprehensive Model of Stepped Care for Substance Misuse Prevention on a College Campus Steven W. Clarke, PhD Director of Health Promotion & Prevention Services Binghamton University Jennifer F. Wagstaff,
SUBSTANCE USE/ABUSE CODING FACT SHEET FOR PRIMARY CARE CLINICIANS
SUBSTANCE USE/ABUSE CODING FACT SHEET FOR PRIMARY CARE CLINICIANS Current Procedural Terminology (CPT ) (Procedure) Codes Initial assessment usually involves a lot of time determining the differential
ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
SWK 3805: Module 2- Introducing Theories of Addiction
SWK 3805: Module 2- Introducing Theories of Addiction SWK 3805: Module 2- Introducing Theories of Addiction DR. AUDREY BEGUN SWK 3805: Module 2- Introducing Theories of Addiction by Dr. Audrey Begun is
Do I Have a Drinking Problem?
People drink for all sorts of reason. Some reasons are to socialize, celebrate and relax. Other times people use alcohol as a form of self-medication to help them manage stress, anxiety or to use it to
Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization
Bulimia Nervosa 3/12/15. Avoidant/Restrictive Food Intake Disorder. Anorexia Nervosa
Avoidant/Restrictive Food Intake Disorder Renamed from Feeding Disorder of infancy or early childhood Renamed to better capture and diagnose what was previously diagnosed as eating disorder NOS Anorexia
An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT
An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)
Clinical Assessment. Client Name (Last, First, MI) ID # Medicaid # DOB: Age:
Clinical Assessment Client Name (Last, First, MI) ID # Medicaid # DOB: Age: Sex: Ethnic Group: Marital Status: Occupation: Education: Multiaxial Diagnosis Axis I: Clinical Disorders / Other Conditions
ASAM CRITERIA 3 rd Edition
ASAM CRITERIA 3 rd Edition Presented by Mark Disselkoen, LCSW, LADC CASAT Based on DSM 5 & The ASAM Criteria Manual The ATTC Network Ten Regional Centers Central Rockies ATTC is now the Mountain Plains
WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS
WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS René Lento, PhD Lauren Brenner, PhD September 25, 2018 DISCLOSURES None HOME BASE PROGRAM 3 LEARNING OBJECTIVES
2/21/2018. What are Opioids?
Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting
Hot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017
Hot Topics in Addiction Medicine Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017 Financial Disclosures Speaker Bureau Indivior Research Support Constellation Health Onward Hot Topics
The Virtual En-psych-lopedia by Dr. Bob. DSM-IV Diagnoses and Codes, Alphabetical Listing
The Virtual En-psych-lopedia by Dr. Bob DSM-IV Diagnoses and Codes, Alphabetical Listing DSM-5 listings: alphabetical, by diagnosis numerical, by ICD-9-CM and ICD-10-CM code This is just an alphabetical
Advances In Measurement Modeling: Bringing Genetic Information Into Preventive Interventions And Getting The Phenotype Right
Advances In Measurement Modeling: Bringing Genetic Information Into Preventive Interventions And Getting The Phenotype Right Bengt Muthen, UCLA bmuthen@ucla.edu 1 Modeling The Influence On A Person s Behavior
Evidence based Practices
Evidence base Practices Adjunct Professor of Psychology, Western Carolina University President, Evince Clinical Assessments Evidence based Treatment Utilize treatment models documented to be effective
Addiction: definition and implications
British Journal of Addiction (1990) 85, 1403-1408 COMMENTARY Addiction: definition and implications AVIEL GOODMAN, M.D. Minnesota Institute of Psychiatry, 1347 Summit Avenue, St Paul, MN 55105, USA Abstract
Co-Occurring Mental Health and Substance Use Disorders. DATE: 11/14/2017 PRESENTED BY: John Mahan, MD
Co-Occurring Mental Health and Substance Use Disorders DATE: 11/14/2017 PRESENTED BY: John Mahan, MD Disclosure Information Speaker: John Mahan, MD has nothing to disclose Learning Objectives Understand
Table of substance use disorder diagnoses:
Table of substance use disorder diagnoses: ICD-9 Codes Description 291 Alcohol withdrawal delirium 291.3 Alcohol-induced psychotic disorder with hallucinations 291.4 Idiosyncratic alcohol intoxication
Alcohol & Drug Use: Roadmap to Certification
Alcohol & Drug Use: Roadmap to Certification Daniel Danczyk, MD, MPH HIMS Psychiatrist / AME / ANG FS / Private Pilot Civil Aviation Medical Association Annual Meeting, Greensboro September 15, 2017 2016
THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved
THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved You can contact this author at sandymorgenthal@yahoo.com
Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11
REVIEW C URRENT OPINION Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11 John B. Saunders a,b Purpose of review The present review compares and contrasts the diagnostic entities
Tobacco Dependence Assessment and Treatment
Tobacco Dependence Assessment and Treatment Jennifer Bluem Moran, M.A. Mayo Clinic Tobacco Treatment Specialist Certification 2013 MFMER slide-1 Outline Motivation Key treatment components Assessment issues
What is the DSM. Diagnostic and Statistical Manual of Mental Disorders Purpose
DSM 5 The Basics What is the DSM Diagnostic and Statistical Manual of Mental Disorders Purpose Standardize diagnosis criteria (objectivity) Assist in research Provide common terminology Public health statistics
Phencyclidine - PCP Originally developed as an anesthetic Street names: angel dust, embalming fluid, rocket fuel, loveboat, super grass, killer weed M
Cannabinoids Most common illicit drug used in the US Signs of marijuana abuse: Inflammation if whites of the eye Rapid, loud speech & bursts of laughter Sleepiness or stupor Forgetfulness in conversation
History of Present Illness (HPI) Assessment and Plan Template
History of Present Illness (HPI) Assessment and Plan Template Templates for induction and follow-up appointments for medication assisted treatment (MAT) in opioid use disorder (OUD). Consider saving this
Introduction to DSM-5
Changes in the Diagnostic and Statistical Manual of Mental s that Impact Forensic Psychology Kristine M. Jacquin, Ph.D. Fielding Graduate University Presented at ACFP Symposium 2014 Overview of Presentation
Clinical Assessment. Client Name (Last, First, MI) ID # Medicaid # DOB: Age: Sex: Ethnic Group: Marital Status: Occupation: Education:
Sex: Ethnic Group: Marital Status: Occupation: Education: Multiaxial Diagnosis Axis I: Clinical Disorders / Other Conditions That May Be a Focus of Clinical Attention Diagnostic Code DSM-IV Name Axis II:
PSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW
TMH Professionals, LLC, American College of Psychotherapy & LPCA present PSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW Module 4: Substance Use Disorders, Impulse Control
FOUR SELF-TESTS: SEXUAL ADDICTION, SEXUAL ANOREXIA, BINGE-PURGE, COLLATERAL INDICATORS
FOUR SELF-TESTS: SEXUAL ADDICTION, SEXUAL ANOREXIA, BINGE-PURGE, COLLATERAL INDICATORS 1. SEXUAL ADDICTION CRITERIA Each of the sexual addiction criteria is listed below. Record whether you think your
Identification and Treatment of Opioid Use Disorders in Primary Care Settings
Identification and Treatment of Opioid Use Disorders in Primary Care Settings 17th Annual Primary Care Symposium February 24, 2018 Kelly S. Barth, DO Associate Professor, Psychiatry & Internal Medicine
CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE
CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE PRESENTED AND APPROVED: DECEMBER 7, 2012 EFFECTIVE: FALL 2013-14 Prefix & Number CHD 110 Purpose of this submission: Change course title to reflect current
Acute General Medical and Surgical Admission:
Acute General Medical and Surgical Admission: Managing Substance Use Disorders in Patients Who are Severely Ill Scott Grantham, MD Executive Director, Behavioral Health Saint Francis Health System By the
What Clergy Need To Know. Deacon Dan Giblin, CRS
What Clergy Need To Know Deacon Dan Giblin, CRS Who am I? Husband and Father Deacon of the Archdiocese of Philadelphia, ordained in 2011 Assigned to St. Ann Parish, Phoenixville Admissions board of St.
Psychosis, Mood, and Personality: A Clinical Perspective
Psychosis, Mood, and Personality: A Clinical Perspective John R. Chamberlain, M.D. Assistant Director, Psychiatry and the Law Program Assistant Clinical Professor University of California San Francisco
Today s Presenter 4/22/2015. ICD-10-CM Documentation and Diagnosis: Behavioral Health. By Tammy Jones, CPC, COC
ICD-10-CM Documentation and Diagnosis: Behavioral Health By Tammy Jones, CPC, COC Today s Presenter Tammy Jones, CPC, COC SVA Healthcare Services, LLC 608.826.2147 jonest@sva.com 1 ICD-10 Documentation
Goal: To recognize and differentiate different patterns of behavior that show evidence of addiction and inadequate impulse-control
Goal: To recognize and differentiate different patterns of behavior that show evidence of addiction and inadequate impulse-control Addiction and Impulse-Control Bad behavior versus sick behavior Is bad
Prescription Drug Monitoring and Toxicology ICD-10-CM. resource guide. Provided as a service of Quest Diagnostics. 1 ICD-10-CM Resource Guide
Prescription Drug Monitoring and Toxicology ICD-10-CM resource guide Provided as a service of Quest Diagnostics 1 ICD-10-CM Resource Guide Table of contents About ICD-10 3 Pain Management: Top Mappings
WHY THE ASI SHOULD BE REPLACED AND WHY MANDATES FOR ITS USE SHOULD BE ELIMINATED
WHY THE ASI SHOULD BE REPLACED AND WHY MANDATES FOR ITS USE SHOULD BE ELIMINATED The ASI (Addiction Severity Index) was initially designed as a program evaluation tool for VA populations and subsequently
Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford
Medication Assisted Treatment of an Opioid Use Disorder J. Craig Allen, MD. Medical Director, Rushford Learning objectives At the conclusion of this activity, participants will be able to: Understand
Optimizing Opioid Dependence Treatment A Guideline for Pharmacists
Optimizing Opioid Dependence Treatment A Guideline for Pharmacists Module 1: Substance Use Concepts F e b r u a r y 2 0 1 5 Learning Objectives To know and understand the pathophysiology of substance dependence,